Inflection Biosciences
0 followers
‌
Inflection Biosciences Ltd is an early stage, drug development company with a focus on discovering and developing innovative small molecule therapeutics addressing major unmet needs in cancer.
Industries
Headquarters
Employees
Links
Org chart
Darren Cunningham
CEO and Co-Founder
Darren Cunningham
Collapse
Tess Barker
Head of Development
Frank Bonner
Head of Non-Clinical Safety
Gemma Carroll
Financial Controller
Kathy Gately
Senior Scientist (Translational Oncology)
Paul Dickinson
CMC: Preclinical and Clinical Formulation Development
David Lathbury
CMC: Process Chemistry
Gerry McGettigan
Regulatory Affairs
